TORRANCE

Navitas Semiconductor to Report Q3 2023 Financial Results on Thursday, November 9th, 2023

Retrieved on: 
Thursday, October 26, 2023
Conference, Broadcasting

TORRANCE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS) today announced that it will report third quarter 2023 financial results after the market close on Thursday, November 9th, 2023.

Key Points: 
  • TORRANCE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS) today announced that it will report third quarter 2023 financial results after the market close on Thursday, November 9th, 2023.
  • Management will host a conference call and live webcast to present the company's financial results and answer questions from the financial analyst community at 2:00 p.m. Pacific / 5:00 p.m. Eastern that same evening.
  • Navitas Q3 2023 Financial Results Conference Call and Webcast Information:
    Toll Free Dial-in: (800) 715-9871 or (646) 307-1963, Conference ID: 5349784

Navitas Spotlights GaNSafe™: World’s Most-Protected GaN Power Semiconductor, at Premier China Electronics Conference

Retrieved on: 
Friday, October 20, 2023
ESD, Survival, Electronics, CPSS, EV, ICS, Congress, News, Conference, Frank Genese, MOSFET, EMI, Gallium nitride, Silicon carbide, Congress Center, PSMA, GM, Navitas, Printed circuit board, Mobile phone, Exhibition

TORRANCE, Calif., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS) announced its continued sponsorship of the 2023 China Power Electronics and Energy Conversion Congress & the 26th China Power Supply Society (CPSS) Conference and Exhibition ( CPSSC 2023 ), revealing major next-generation gallium nitride (GaN) and silicon carbide (SiC) power semiconductor platforms, including GaNSafe™ - the world’s safest GaN power semiconductor.

Key Points: 
  • TORRANCE, Calif., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS) announced its continued sponsorship of the 2023 China Power Electronics and Energy Conversion Congress & the 26th China Power Supply Society (CPSS) Conference and Exhibition ( CPSSC 2023 ), revealing major next-generation gallium nitride (GaN) and silicon carbide (SiC) power semiconductor platforms, including GaNSafe™ - the world’s safest GaN power semiconductor.
  • Navitas is the technology and market leader in GaN, with over 100 million GaNFast™ power ICs shipped, and over 12 million GeneSiC™ power MOSFETs and diodes shipped into a $22 billion per year total market opportunity.
  • With GaNSafe, Navitas has optimized its 4th-generation GaN technology for demanding, high-power applications in data centers, solar / energy storage and EV markets, where efficiency, power density and robust & reliable operation are critical.
  • Visitors to the exhibition will discover ground-breaking technology demonstrations and complete power system platform designs at the Navitas booth.

CORRECTION: Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New England Journal of Medicine

Retrieved on: 
Wednesday, October 11, 2023
Chlorhexidine, Infection, Methicillin-resistant Staphylococcus aureus, Nursing, Doctor of Philosophy, The New England Journal of Medicine, Prevalence, Epidemiology, UCI, Hospital, MPH, University of California, Irvine, University, CDC, Agency for Healthcare Research and Quality, University of California, Irvine School of Medicine, Health, Harbor–UCLA Medical Center, AHRQ, MHSA, Nursing home, Fungal infection, Long-term care, MRSA, Povidone-iodine, Houston, Clinical trial, Nose, Institute of Health and Biomedical Innovation, Korea Disease Control and Prevention Agency, Skin, UCI School of Biological Sciences, Urinary tract infection, Enterococcus-1 RNA motif, Bed, Research, NIH, Pharmaceutical industry, MD, Medicine

The findings were published on October 10, 2023, in the New England Journal of Medicine.

Key Points: 
  • The findings were published on October 10, 2023, in the New England Journal of Medicine.
  • “The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.
  • Dr. Miller is the Chief of Infectious Diseases at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Torrance, California.
  • “Nursing Home Decolonization for Infection and Hospitalization Prevention” published in the New England Journal of Medicine on October 10, 2023: https://www.nejm.org/doi/full/10.1056/NEJMoa2215254?query=featured_home

Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New English Journal of Medicine

Retrieved on: 
Tuesday, October 10, 2023
Chlorhexidine, Infection, Methicillin-resistant Staphylococcus aureus, Nursing, Doctor of Philosophy, The New England Journal of Medicine, Prevalence, Epidemiology, UCI, Hospital, MPH, University of California, Irvine, CDC, University, Agency for Healthcare Research and Quality, University of California, Irvine School of Medicine, Health, Harbor–UCLA Medical Center, AHRQ, MHSA, Fungal infection, Long-term care, MRSA, Povidone-iodine, Houston, Clinical trial, Nose, Institute of Health and Biomedical Innovation, Korea Disease Control and Prevention Agency, Skin, UCI School of Biological Sciences, Urinary tract infection, Enterococcus-1 RNA motif, Bed, Research, NIH, Pharmaceutical industry, MD, Medicine

“The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.

Key Points: 
  • “The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.
  • Dr. Miller is the Chief of Infectious Diseases at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Torrance, California.
  • Each year, 3 million healthcare-associated infections (HAIs) such as methicillin-resistant Staphylococcus aureus (MRSA), bloodstream and urinary tract infections occur in U.S. nursing homes.
  • The findings add to a growing body of Dr. Miller’s research that has been funded by NIH, AHRQ, and other federal sources.

Navitas Announces Comprehensive Investor Day, 2023

Retrieved on: 
Thursday, September 21, 2023
EV, Electronics

TORRANCE, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS) announced the 2023 Investor Day, to be held at the company’s new headquarters, on Tuesday 12th December, 2023.

Key Points: 
  • TORRANCE, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS) announced the 2023 Investor Day, to be held at the company’s new headquarters, on Tuesday 12th December, 2023.
  • Four major new GaN/SiC technology platforms and five focus markets, including new GaNSafe technology, positioned to revolutionize AI-based data centers, EV, and renewable applications.
  • $1B+ customer pipeline & what this means to Navitas growth trajectory, with a preview of 2024 forecast and long-term targets.
  • Navitas’ unique, detailed view on the past, present and future of power electronics as we look to “Electrify Our World” (guided tour, and management small-group meetings).

CarbonBuilt® Eliminates Use of Ordinary Portland Cement to Make Commercial Concrete Products with Near-zero Embodied Carbon

Retrieved on: 
Thursday, September 21, 2023
OPC, CO2, Carbon, Cement

Leveraging the company’s core technology, this low-cost, low-carbon cement alternative chemically reacts with captured CO2 to create concrete blocks that perform the same as and cost no more to make than traditional products, yet contain near zero-to-negative embodied carbon.

Key Points: 
  • Leveraging the company’s core technology, this low-cost, low-carbon cement alternative chemically reacts with captured CO2 to create concrete blocks that perform the same as and cost no more to make than traditional products, yet contain near zero-to-negative embodied carbon.
  • CarbonBuilt and Blair Block intend to produce these blocks at commercial volume in early 2024.
  • The resulting concrete blocks look the same, perform the same and meet all the same building and industry standards as traditional products, but with 70-100+% less embodied carbon.
  • CarbonBuilt’s curing technology bolts on to existing concrete manufacturing plants where the combination of lower input costs and shared carbon credit revenue enables producers to make ultra-low carbon concrete without any compromises.

Lundquist Investigator Dr. Harry Rossiter Awarded $3.8 Million NIH Grant To Develop the Next-Generation Cardiopulmonary Exercise Test

Retrieved on: 
Wednesday, September 20, 2023
Exercise, Heart, David Geffen School of Medicine at UCLA, TLI, R01, Research, Doctor of Philosophy, Bangladesh Technical Education Board, Athlete, Gold, Patient, 4-HO-McPeT, CPET, UCLA, Harbor–UCLA Medical Center, NIH, Disease, Medical device, Medicine

The R01 is the most prestigious and competitive NIH grant (only 10% are funded) awarded to biomedical researchers.

Key Points: 
  • The R01 is the most prestigious and competitive NIH grant (only 10% are funded) awarded to biomedical researchers.
  • Dr. Rossiter’s research team at TLI has developed the next generation of the cardiopulmonary exercise test; the standard clinical test to investigate exercise intolerance.
  • “This research builds on what Lundquist Institute investigators developed fifty years ago,” said David I. Meyer, TLI President and CEO.
  • “This next-generation CPET being developed by Dr. Rossiter and his team will become the new gold standard for clinical investigation of exercise intolerance.”

Criminal IP, a CTI Search Engine, Attains PCI DSS Level 1 Certification

Retrieved on: 
Thursday, September 14, 2023
Chrome, Certification, Cyber threat intelligence, PCI, Merchant, Payment Card Industry Data Security Standard, PCI DSS, Crime, Risk, IP, Spera, Payment card, Online shopping

AI Spera is pleased to announce its attainment of the highest global compliance certification level, PCI DSS Level 1 for Criminal IP , its in-house developed and serviced Cyber Threat Intelligence search engine.

Key Points: 
  • AI Spera is pleased to announce its attainment of the highest global compliance certification level, PCI DSS Level 1 for Criminal IP , its in-house developed and serviced Cyber Threat Intelligence search engine.
  • Criminal IP has achieved the certification of top-tier global compliance, PCI DSS Level 1, in E-commerce (Merchant)
    To view an enhanced version of this graphic, please visit:
    The Payment Card Industry Data Security Standard (PCI DSS) is a global information security standard designed to safeguard card payment information and transactions.
  • Criminal IP has achieved the highest level of compliance, PCI DSS Level 1 certification.
  • With these enhancements, Criminal IP reflects its dedication to delivering the best possible detection and protection service to users worldwide.

Navitas’ SiC Experts Take Center Stage at ICSCRM 2023

Retrieved on: 
Thursday, September 14, 2023
History, Silicon, Silicon carbide, Frank Genese, International conference on Physics of Light–Matter Coupling in Nanostructures, MOSFET, Solar energy, Conference, Music

TORRANCE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS) announced participation at the International Conference on Silicon Carbide and Related Materials (ICSCRM) 2023, to be held in Sorrento, Italy.

Key Points: 
  • TORRANCE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS) announced participation at the International Conference on Silicon Carbide and Related Materials (ICSCRM) 2023, to be held in Sorrento, Italy.
  • The ICSCRM conference fosters collaboration and knowledge sharing among the brightest minds in the field.
  • The session, titled "Devices 4: Short circuit, avalanche and reliability," will focus on crucial topics in the field of SiC technology.
  • “As a pioneer in the field, we continue to extend the boundaries of SiC technology, revolutionizing power semiconductors with cutting-edge GeneSiC™ technology.”